血栓塞栓症(Thromboembolism)：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Thromboembolism 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Thromboembolism to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Thromboembolism to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Thromboembolism 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Thromboembolism Therapeutics Clinical Trials 33
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
C. H. Boehringer Sohn AG & Co. KG 35
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 35
Bayer AG 40
Clinical Trial Overview of Bayer AG 40
Sanofi 43
Clinical Trial Overview of Sanofi 43
GlaxoSmithKline plc 45
Clinical Trial Overview of GlaxoSmithKline plc 45
Pfizer Inc. 47
Clinical Trial Overview of Pfizer Inc. 47
Bristol-Myers Squibb Company 49
Clinical Trial Overview of Bristol-Myers Squibb Company 49
Astellas Pharma Inc. 51
Clinical Trial Overview of Astellas Pharma Inc. 51
Daiichi Sankyo Company, Limited 53
Clinical Trial Overview of Daiichi Sankyo Company, Limited 53
AstraZeneca PLC 55
Clinical Trial Overview of AstraZeneca PLC 55
Johnson & Johnson 57
Clinical Trial Overview of Johnson & Johnson 57
Clinical Trial Overview of Top Institutes / Government 58
Beijing Chao-Yang Hospital 58
Clinical Trial Overview of Beijing Chao-Yang Hospital 58
McMaster University 59
Clinical Trial Overview of McMaster University 59
Ottawa Hospital Research Institute 60
Clinical Trial Overview of Ottawa Hospital Research Institute 60
Capital District Health Authority, Canada 61
Clinical Trial Overview of Capital District Health Authority, Canada 61
Hamilton Health Sciences 62
Clinical Trial Overview of Hamilton Health Sciences 62
National Institutes of Health Clinical Center 63
Clinical Trial Overview of National Institutes of Health Clinical Center 63
Seoul National University Hospital 64
Clinical Trial Overview of Seoul National University Hospital 64
The Utrecht Institute for Pharmaceutical Sciences 65
Clinical Trial Overview of The Utrecht Institute for Pharmaceutical Sciences 65
Universita degli Studi dell’Insubria 66
Clinical Trial Overview of Universita degli Studi dell’Insubria 66
Five Key Clinical Profiles 67
Appendix 94
Abbreviations 94
Definitions 94
Research Methodology 95
Secondary Research 95
About GlobalData 96
Contact Us 96
Disclaimer 96
Source 96